Development of a Langerhans cell-targeted gene therapy format using a dendritic cell-specific promoter

A. Morita, K. Ariizumi, R. Ritter, J. V. Jester, T. Kumamoto, Stephen Johnston, A. Takashima

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Langerhans cells (LC), which are a skin-specific member of the dendritic cell (DC) family of antigen presenting cells, play critical roles in the initiation of cellular immune responses in the skin. We developed a LC-targeted gene therapy format in this study, aimed at the establishment of in situ protocols for genetic manipulation of LC function. Dectin-2 is a unique C-type lectin that is expressed selectively by DC, including epidermal LC. A 3.2 kb 5′ flanking fragment isolated from the mouse dectin-2 gene, termed the dectin-2 promoter (pDec2), exhibited significant transcriptional activities in epidermal-derived DC lines of the XS series, but not in any of the tested non-DC lines. When pDec2-driven luciferase gene (pDec2-Luc) or enhanced green fluorescence protein gene (pDec2-EGFP) was delivered to mouse skin using the gene gun, expression of the corresponding gene product was observed in the epidermal compartment almost exclusively by the IA+ population (ie LC). LC in the gene gun-treated sites showed features of mature DC and they migrated to the draining lymph node, suggesting that LC-targeted gene expression may lead to the development of immune responses. In fact, EGFP-specific cellular immune responses became detectable after gene gun-mediated delivery of pDec2-EGFP plasmid. These results introduce a new concept that LC function can be genetically manipulated in situ by the combination of gene gun-mediated DNA delivery and a DC-specific promoter.

Original languageEnglish (US)
Pages (from-to)1729-1737
Number of pages9
JournalGene Therapy
Volume8
Issue number22
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Langerhans Cells
Genetic Therapy
Dendritic Cells
Firearms
Genes
Cellular Immunity
Skin
Fluorescence
C-Type Lectins
Gene Expression
Cell Line
Antigen-Presenting Cells
Luciferases
Proteins
Plasmids
Lymph Nodes

Keywords

  • Dectin-2 promoter
  • Dendritic cells
  • Gene gun
  • Langerhans cells
  • Transcriptional regulation

ASJC Scopus subject areas

  • Genetics

Cite this

Morita, A., Ariizumi, K., Ritter, R., Jester, J. V., Kumamoto, T., Johnston, S., & Takashima, A. (2001). Development of a Langerhans cell-targeted gene therapy format using a dendritic cell-specific promoter. Gene Therapy, 8(22), 1729-1737. https://doi.org/10.1038/sj.gt.3301580

Development of a Langerhans cell-targeted gene therapy format using a dendritic cell-specific promoter. / Morita, A.; Ariizumi, K.; Ritter, R.; Jester, J. V.; Kumamoto, T.; Johnston, Stephen; Takashima, A.

In: Gene Therapy, Vol. 8, No. 22, 2001, p. 1729-1737.

Research output: Contribution to journalArticle

Morita, A, Ariizumi, K, Ritter, R, Jester, JV, Kumamoto, T, Johnston, S & Takashima, A 2001, 'Development of a Langerhans cell-targeted gene therapy format using a dendritic cell-specific promoter', Gene Therapy, vol. 8, no. 22, pp. 1729-1737. https://doi.org/10.1038/sj.gt.3301580
Morita, A. ; Ariizumi, K. ; Ritter, R. ; Jester, J. V. ; Kumamoto, T. ; Johnston, Stephen ; Takashima, A. / Development of a Langerhans cell-targeted gene therapy format using a dendritic cell-specific promoter. In: Gene Therapy. 2001 ; Vol. 8, No. 22. pp. 1729-1737.
@article{6792dc30e4ca4e71b795891b906e4c0f,
title = "Development of a Langerhans cell-targeted gene therapy format using a dendritic cell-specific promoter",
abstract = "Langerhans cells (LC), which are a skin-specific member of the dendritic cell (DC) family of antigen presenting cells, play critical roles in the initiation of cellular immune responses in the skin. We developed a LC-targeted gene therapy format in this study, aimed at the establishment of in situ protocols for genetic manipulation of LC function. Dectin-2 is a unique C-type lectin that is expressed selectively by DC, including epidermal LC. A 3.2 kb 5′ flanking fragment isolated from the mouse dectin-2 gene, termed the dectin-2 promoter (pDec2), exhibited significant transcriptional activities in epidermal-derived DC lines of the XS series, but not in any of the tested non-DC lines. When pDec2-driven luciferase gene (pDec2-Luc) or enhanced green fluorescence protein gene (pDec2-EGFP) was delivered to mouse skin using the gene gun, expression of the corresponding gene product was observed in the epidermal compartment almost exclusively by the IA+ population (ie LC). LC in the gene gun-treated sites showed features of mature DC and they migrated to the draining lymph node, suggesting that LC-targeted gene expression may lead to the development of immune responses. In fact, EGFP-specific cellular immune responses became detectable after gene gun-mediated delivery of pDec2-EGFP plasmid. These results introduce a new concept that LC function can be genetically manipulated in situ by the combination of gene gun-mediated DNA delivery and a DC-specific promoter.",
keywords = "Dectin-2 promoter, Dendritic cells, Gene gun, Langerhans cells, Transcriptional regulation",
author = "A. Morita and K. Ariizumi and R. Ritter and Jester, {J. V.} and T. Kumamoto and Stephen Johnston and A. Takashima",
year = "2001",
doi = "10.1038/sj.gt.3301580",
language = "English (US)",
volume = "8",
pages = "1729--1737",
journal = "Gene Therapy",
issn = "0969-7128",
publisher = "Nature Publishing Group",
number = "22",

}

TY - JOUR

T1 - Development of a Langerhans cell-targeted gene therapy format using a dendritic cell-specific promoter

AU - Morita, A.

AU - Ariizumi, K.

AU - Ritter, R.

AU - Jester, J. V.

AU - Kumamoto, T.

AU - Johnston, Stephen

AU - Takashima, A.

PY - 2001

Y1 - 2001

N2 - Langerhans cells (LC), which are a skin-specific member of the dendritic cell (DC) family of antigen presenting cells, play critical roles in the initiation of cellular immune responses in the skin. We developed a LC-targeted gene therapy format in this study, aimed at the establishment of in situ protocols for genetic manipulation of LC function. Dectin-2 is a unique C-type lectin that is expressed selectively by DC, including epidermal LC. A 3.2 kb 5′ flanking fragment isolated from the mouse dectin-2 gene, termed the dectin-2 promoter (pDec2), exhibited significant transcriptional activities in epidermal-derived DC lines of the XS series, but not in any of the tested non-DC lines. When pDec2-driven luciferase gene (pDec2-Luc) or enhanced green fluorescence protein gene (pDec2-EGFP) was delivered to mouse skin using the gene gun, expression of the corresponding gene product was observed in the epidermal compartment almost exclusively by the IA+ population (ie LC). LC in the gene gun-treated sites showed features of mature DC and they migrated to the draining lymph node, suggesting that LC-targeted gene expression may lead to the development of immune responses. In fact, EGFP-specific cellular immune responses became detectable after gene gun-mediated delivery of pDec2-EGFP plasmid. These results introduce a new concept that LC function can be genetically manipulated in situ by the combination of gene gun-mediated DNA delivery and a DC-specific promoter.

AB - Langerhans cells (LC), which are a skin-specific member of the dendritic cell (DC) family of antigen presenting cells, play critical roles in the initiation of cellular immune responses in the skin. We developed a LC-targeted gene therapy format in this study, aimed at the establishment of in situ protocols for genetic manipulation of LC function. Dectin-2 is a unique C-type lectin that is expressed selectively by DC, including epidermal LC. A 3.2 kb 5′ flanking fragment isolated from the mouse dectin-2 gene, termed the dectin-2 promoter (pDec2), exhibited significant transcriptional activities in epidermal-derived DC lines of the XS series, but not in any of the tested non-DC lines. When pDec2-driven luciferase gene (pDec2-Luc) or enhanced green fluorescence protein gene (pDec2-EGFP) was delivered to mouse skin using the gene gun, expression of the corresponding gene product was observed in the epidermal compartment almost exclusively by the IA+ population (ie LC). LC in the gene gun-treated sites showed features of mature DC and they migrated to the draining lymph node, suggesting that LC-targeted gene expression may lead to the development of immune responses. In fact, EGFP-specific cellular immune responses became detectable after gene gun-mediated delivery of pDec2-EGFP plasmid. These results introduce a new concept that LC function can be genetically manipulated in situ by the combination of gene gun-mediated DNA delivery and a DC-specific promoter.

KW - Dectin-2 promoter

KW - Dendritic cells

KW - Gene gun

KW - Langerhans cells

KW - Transcriptional regulation

UR - http://www.scopus.com/inward/record.url?scp=0035659945&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035659945&partnerID=8YFLogxK

U2 - 10.1038/sj.gt.3301580

DO - 10.1038/sj.gt.3301580

M3 - Article

C2 - 11892841

AN - SCOPUS:0035659945

VL - 8

SP - 1729

EP - 1737

JO - Gene Therapy

JF - Gene Therapy

SN - 0969-7128

IS - 22

ER -